Accordant Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72.3K Hold
563
0.05% 77
2026
Q1
$67.7K Hold
563
0.04% 77
2025
Q4
$59.3K Hold
563
0.04% 75
2025
Q3
$47.3K Hold
563
0.03% 88
2025
Q2
$44.6K Hold
563
0.03% 86
2025
Q1
$50.5K Hold
563
0.05% 65
2024
Q4
$56K Hold
563
0.05% 64
2024
Q3
$63.9K Hold
563
0.05% 63
2024
Q2
$69.7K Sell
563
-6,270
-92% -$808K 0.07% 66
2024
Q1
$902K Buy
+6,833
New +$842K 0.67% 38

Other funds holding MRK

Accordant Advisory Group's MRK Position: Q2 2026 in Review

Accordant Advisory Group held its Merck (MRK) position steady in Q2 2026 at 563 shares worth $72.3K. The position accounts for 0.05% of the portfolio, ranked #77.

Accordant Advisory Group first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $902K in Q1 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Accordant Advisory Group held 563 shares of Merck worth $72.3K as of Q2 2026.
  • Accordant Advisory Group left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.05% of Accordant Advisory Group's portfolio in Q2 2026, its #77 holding.
  • Accordant Advisory Group first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • Accordant Advisory Group's Merck position peaked at $902K in Q1 2024.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Accordant Advisory Group's 13F filing for Q2 2026, filed 27 Jul 2026.